Since egr-1 is critical in proliferation, differentiation, and inflammation during cholestatic liver injury, cytokine and growth factor generation and early extracellular matrix (collagen) formation (Zhang et al., 2011), BPC 157 (with nab2) may have an essential role as a particular feedback-controlling mechanism
The investigators found that topical BPC-157 significantly accelerated wound closure compared to control treatments
This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available
First 2 weeks: reduced inflammation, improved mobility in acute injuries Weeks 34: measurable reduction in pain
It does not require encapsulation, a carrier molecule, or special formulation to maintain structural integrity in biological environments
For researchers who wish to explore both compounds without managing two separate reconstitutions, the BPC 157 5mg + TB 500 5mg Blend (10mg) offers a convenient combined vial at equal 1:1 ratios the most commonly referenced ratio in published blend studies